Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, LVS Advisory - Growth. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+30%
YTD+30%
Annualized+77.1%
Positioning StanceCONSTRUCTIVE
GeographyUS
Digest Analysis
Quick Take
"LVS Advisory demonstrated disciplined risk management in Q1 2025 by selling Howard Hughes due to unfavorable activist dynamics and Icon after discovering flawed M&A synergies. Both portfolios outperformed the declining S&P 500."
Executive Summary
LVS Advisory's Q1 2025 letter focuses on risk management through strategic selling rather than new purchases. The Event-Driven Portfolio gained 0.8% while the Growth Portfolio gained 0.3%, both outperforming the S&P 500's -4.3% decline. The manager sold Howard Hughes Corp after Bill Ackman's increasingly unfavorable takeover proposals threatened minority shareholders, exiting at $76.80 for a slight profit from the $74.55 entry. The firm also exited Icon Plc after research revealed that the CRO's aggressive M&A strategy failed to deliver promised synergies and that serving small biotech companies (like Medpace does) represents a superior business model compared to serving large pharma. Both sales demonstrate the firm's commitment to selling when investment theses change or management cannot be trusted. The letter emphasizes extensive research validation to avoid costly mistakes, with proceeds from Icon redirected to double down on the preferred Medpace position. LVS Advisory added analyst Daniel Yuan to support research efforts.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
75%
Market Conviction
Conviction is scored at 0.75, demonstrated by the manager's willingness to quickly and fully liquidate positions like Howard Hughes and Icon Plc immediately when the thesis is violated. Additionally, they concentrated their capital by doubling down on their high-conviction position in Medpace rather than maintaining broad diversification.
75%
Growth Outlook
The manager does not discuss broader market projections or macroeconomic outlook in this letter, focusing instead on individual stock sales and risk management processes. Thus, a neutral score of 0.50 is assigned.
75%
Risk Appetite
The portfolio shows a balanced risk appetite at 0.50, as the manager is actively managing risk by exiting names with broken theses (Howard Hughes and Icon Plc) while simultaneously doubling down on existing high-conviction holdings like Medpace rather than purely moving to cash.
40%
Capital Deployment
Capital deployment is scored at 0.40, representing moderate de-risking or capital reallocation. While the proceeds from selling Icon Plc were redeployed into Medpace, the exit from Howard Hughes represents a net reduction in holdings during the quarter.
75%
Forward Guidance
Forward guidance is scored at 0.50 because the letter focuses on retrospective portfolio sales during the quarter rather than future deployment guidance or macro targets. The manager highlights their discipline in selling when a thesis breaks but does not provide explicit buy targets or market entry signals.
75%
Language Signal
The language signal is balanced at 0.50, reflecting a mixture of negative terms associated with exiting broken theses (such as 'disaster project,' 'incinerating cash,' 'cracks in the story,' 'flaws') offset by constructive, disciplined vocabulary on risk management and doubling down on Medpace.
60%
Perceived Risk
Perceived risk is scored at 0.60. Although the letter does not discuss systemic macro risks, it focuses heavily on micro-level risks including corporate governance and activist misalignment (Bill Ackman at Howard Hughes) as well as operational M&A integration failure (Icon Plc).
50%
Opportunity Density
Opportunity density is scored at 0.50, indicating a highly selective environment. The manager did not highlight any new buying opportunities, instead focusing on capital allocation adjustments within a narrow set of existing positions.
70%
Time Horizon
Time horizon is scored at 0.70. The manager evaluates investments based on multi-year trends, such as the CRO industry's long-term tailwinds and long-term M&A integration success, rather than short-term price movements.